真核延长因子eEF1A功能研究进展

程君; 芮耀诚

doi:10.3969/j.issn.1006-0111.2012.02.003

真核延长因子eEF1A功能研究进展

doi: 10.3969/j.issn.1006-0111.2012.02.003

程君,
芮耀诚

第二军医大学药学院药理学教研室, 上海 200433

Advance in function of the eukaryotic elongation factor eEF1A

Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai 200433, China

摘要: 真核延长因子(eEFs)是一类在蛋白质合成过程中发挥肽链延伸作用的重要分子,在真核生物体内它有eEF1和eEF2两个亚型。其中在肽链延伸过程中起主要作用的eEF1A 是eEF1的一个亚型,它不但能促进氨酰基-tRNA(aa-tRNA)与核糖体的A位点结合,发挥肽链延伸功能;而且近年来大量的研究表明它在细胞凋亡、肿瘤的发生、细胞内信号转导及心血管系统的调节方面均发挥了重要作用,而且这些作用与它在蛋白合成中的功能无关;这表明eEF1A是一个多功能蛋白,能够成为一个潜在的疾病防治的靶点。本文就国内外近几年来有关eEF1A的研究做一综述,介绍真核延长因子eEF1A功能研究的进展。
- 真核延长因子eEF1A /
- 蛋白合成 /
- 细胞凋亡 /
- 肿瘤 /
- 心血管系统
Abstract: Eukaryotic elongation factors(eEFs)was a kind of important molecules that assist in elongating the polypeptide chain in the protein biosynthesis of the organisms. It had two subtypes in eukaryotic organism:eEF1 and eEF2. One subtype of eEF1:eEF1A played the main functions in elongating the peptide chain, which carried the aminoacyl-tRNA (aa-tRNA)on the A site of the ribosome,and many studies indicated that eEF1A played another roles range from cell apoptosis,tumorigenesis,signal transduction to the regulation of the cardiovascular system, and these functions were not related to the protein synthesis. All of this demonstrated eEF1A was a multifunction protein,which could be a potential target of the disease prevention and cure. The advance in function of the eukaryotic elongation factor eEF1A in recently years were introduced in this article.
- eukaryotic elongation factor eEF1A /
- protein biosynthesis /
- cell apoptosis /
- tumor /
- cardiovascular system

[1]	Lamberti A,araglia M,longo O,et al.The translation elongation factor 1A in tumorigenesis, signal transduction and apoptosis[J]. Amino Acids,2004,26(4):443.
[2]	Infante C,sensio E,aavate JP,et al. Molecular characterization and expression analysis of five different elongation factor 1 alpha genes in the flatfish Senegalese sole (Solea senegalensis Kaup): Differential gene expression and thyroid hormones dependence during metamorphosis[J]. BMC Mol Biol,2008,9:19.
[3]	Maria K,Mateyak,Kinzy TG. eEF1A: Thinking outside the ribosome[J]. J Biol Chem,2010,5(4):432.
[4]	Ejiri Shin ichiro. Moonlighting functions of polypeptide elongation factor 1:from actin bundling to zinc finger protein r1-associated nuclear localization[J]. Biotechnol Biochem,2002,66(1):1.
[5]	Khalyfa A,Bourbeau D,Chen E,et al. Characterization of Elongation Factor-1A (eEF1A-1) and eEF1A-2/S1 Protein Expression in Normal and wasted Mice[J]. J Biol Chem,2001,276(25):22915.
[6]	Newbery HJ,Loh DH,Donoghue JE,et al. Translation elongation factor eEF1A2 is essential for post-weaning survival in mice[J]. J Biol Chem,2007,282(39):28951.
[7]	Pan J,Ruest LB,Xu SY,et al. Immuno-characterization of the switch of peptide elongation factors eEF1A-1/EF-1a and eEF1A-2/S1 in the central nervous system during mouse development[J]. Dev Brain Res,2004,149:1.
[8]	Andersen GR,Nissen P,Nyborg J. Elongation factors in protein biosynthesis[J]. Trends Biochem Sci,2003,28(8):434.
[9]	Villa E,Sengupta J,Trabuco LG,et al. Ribosome-induced changes in elongation factor Tu conformation control GTP hydrolysis[J]. Proc Natl Acad Sci,2009,106(4):1063.
[10]	Ruest LB,Marcotte R,Wang E. Peptide elongation factor eEF1A-2/S1 expression in cultured differentiated myotubes and its protective effect against caspase3-mediated apoptosis[J]. J Biol Chem,2002,277(7):5418.
[11]	Borradaile NM, Buhman KK, Listenberger LL, et al. A critical role for eukaryotic elongation factor 1A1 in lipotoxic cell death[J]. Mol Biol Cell,2006,17:770.
[12]	Talapatra1 S,Wagner J,Thompson CB. Elongation factor-1 alpha is a selective regulator of growth factor withdrawal and ER stress-induced apoptosis[J]. Cell Death and Differ, 2002,9:856.
[13]	Li HT,Su YP,Cheng TM,et al. The interaction between interferon-induced protein with tetratricopeptide repeats-1 and eukaryotic elongation factor-1A[J]. Mol Cell Biochem,2010, 337:101.
[14]	Mansillaa F,Hansenb LL,Jakobsena H,et al. Deconstructing PTI-1: PT1-1 is a truncated, but not mutated form of translation elongation factor 1A1, eEF1A1[J]. Biochim Biophys Acta,2005,1727(2):116.
[15]	Zhang JP,Guo HT,Mi ZY,et al. EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells[J]. Exp Cell Res,2009,315:304.
[16]	Anand N,Urthy S,Mann G,et al.Protein elongation factor eEF1A2 is a putative oncogene in ovarian cancer[J]. Nat Genet,2002,31:301.
[17]	Tomlinson VA,ewbery HJ,ray NR,et al. Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours[J]. BMC cancer,2005,5:113.
[18]	Morikawa E,Moskowitz M,Huang Z,et al. L-Arginine infusion promotes nitric oxide dependent vasodilation,increases regional blood flow and reduces infarct volume in the rat[J]. Stroke,1994,25(2):429.
[19]	Yan GJ,You B,Chen SP,et al. Tumor necrosis factor-a downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1A1[J]. Circ Res,2008,103(12):591.
[20]	Picchi A,Gao X,Belmadani S. Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome[J]. Circ Res,2006,99:69.
[21]	Agnoletti L,Curello S,Bachetti T,et al. Serum from patients with severe heart failure downregulates eNOS and is proapoptotic:role of tumor necrosis factor-alpha[J]. Circulation, 1999,100:1983.
[22]	Gross SR,Kinzy TG. Tranlation elongation factor 1A is essential for regulation of actin cytoskeleton and cell morphology[J]. Nat Struct Mol Boil,2005,12:772.
[23]	Leclercq TM, Moretti PAB, Vadas MA, et al.Eukaryotic elongation factor 1A interacts with sphingosine kinase and directly enhances its catalytic activity[J]. J Biol Chem,2008,283:9606.
[24]	Gillardon F. Interaction of elongation factor 1-a with leucine-rich repeat kinase 2 impairs kinase activity and microtubule bundling in vitro[J]. Neuroscience,2009,163:533.
[25]	Yuka Hotokezaka,Udo Tobben,Hitoshi Hotokezaka,et al. Interaction of the Eukaryotic Elongation Factor 1A with NewlySynthesized Polypeptides[J]. J Biol Chem,2002,277(21):18545.
[26]	Shamovsky Iiya,Ivannikov Maxim,Kandel ES,et al. RNA-mediated response to heart shock in mammalian cells[J]. Nature,2006,440(23):556.

[1]	王文涛, 高兴, 赵凤平, 郑灿辉, 陈新. 异硒唑酮类化合物在疾病治疗中的作用和化学合成方法研究 . 药学实践与服务, 2025, 43(): 1-7. doi: 10.12206/j.issn.2097-2024.202308064
[2]	王彦, 康乐, 陈文, 方琦, 俞仲望, 曹莉. 基于CiteSpace结合系统评价方法分析药品不良反应自动监测系统的热点及优势 . 药学实践与服务, 2025, 43(): 1-8. doi: 10.12206/j.issn.2097-2024.202501034
[3]	李惠萍, 陈璐, 张琪金, 黄宝康. 紫苏叶挥发油成分的生物合成、含量测定及生物活性研究进展 . 药学实践与服务, 2025, 43(): 1-6. doi: 10.12206/j.issn.2097-2024.202412058
[4]	卢熠菲, 宋佳, 沈红霞, 赵庆杰. 新型苦参碱衍生物的设计合成与体外抗炎活性研究 . 药学实践与服务, 2025, 43(): 1-8. doi: 10.12206/j.issn.2097-2024.202503005
[5]	魏莱, 董国强. SARS-CoV-2主蛋白酶抑制剂和降解剂研究进展 . 药学实践与服务, 2025, 43(6): 259-269, 297. doi: 10.12206/j.issn.2097-2024.202503064
[6]	詹济华, 颜滢. 低蛋白血症对头孢哌酮舒巴坦血药浓度的影响 . 药学实践与服务, 2025, 43(): 1-4. doi: 10.12206/j.issn.2097-2024.202309040
[7]	冯婷婷, 张景翔, 王彦, 许维恒, 张俊平. ANXA3基因及蛋白的研究进展 . 药学实践与服务, 2025, 43(2): 47-50, 74. doi: 10.12206/j.issn.2097-2024.202309023
[8]	李娜, 黄诚文, 孙秀娟, 王晓红, 张丽, 王兴坡. 奥希替尼与吉非替尼治疗表皮生长因子受体突变的晚期非小细胞肺癌的成本效果分析 . 药学实践与服务, 2025, 43(): 1-6. doi: 10.12206/j.issn.2097-2024.202411032
[9]	赵全公, 王国坤, 徐志云. 虾青素通过激活Nrf2/HO-1通路抑制瓣膜间质细胞钙化 . 药学实践与服务, 2025, 43(6): 283-287. doi: 10.12206/j.issn.2097-2024.202412057
[10]	杨金润, 黎翔, 孙旸. ORM1促肝细胞增殖的作用及其机制探索 . 药学实践与服务, 2025, 43(5): 222-227. doi: 10.12206/j.issn.2097-2024.202410014
[11]	柯刚, 董清科, 肖世容, 龚茜, 李荣, 汪代杰. 基于网络药理学探讨参苓白术散治疗肿瘤恶病质的作用机制 . 药学实践与服务, 2025, 43(5): 242-250. doi: 10.12206/j.issn.2097-2024.202208115
[12]	魏莱, 董国强, 盛春泉. 靶向SARS-CoV-2主蛋白酶的PROTAC设计、合成与蛋白降解活性研究 . 药学实践与服务, 2025, 43(5): 235-241, 258. doi: 10.12206/j.issn.2097-2024.202503063
[13]	郭静, 康金龙, 李强, 赵琳, 刘骥, 徐学武. 利多卡因不同给药途径对麻醉诱导气管插管心血管应激反应的抑制作用 . 药学实践与服务, 2025, 43(6): 303-306. doi: 10.12206/j.issn.2097-2024.202502009
[14]	徐尧, 马春辉, 李志勇. 高血压对大鼠心血管纤维化及sFRP2表达的影响 . 药学实践与服务, 2025, 43(4): 180-184. doi: 10.12206/j.issn.2097-2024.202409055
[15]	施乔, 韩贵焱, 张俊腾, 刘娜. 新型Hsp90抑制剂的设计合成及其抗真菌和抗肿瘤活性研究 . 药学实践与服务, 2025, 43(3): 124-135. doi: 10.12206/j.issn.2097-2024.202501019
[16]	周娇, 郑建雨, 王思真, 杨峰. mRNA肿瘤疫苗非病毒递送系统研究进展 . 药学实践与服务, 2025, 43(3): 109-116. doi: 10.12206/j.issn.2097-2024.202410034
[17]	吴若南, 汤文敏, 高林, 吴岳林, 罗川, 缪震元. RRx-001衍生物的合成和抗肿瘤活性研究 . 药学实践与服务, 2025, 43(): 1-5. doi: 10.12206/j.issn.2097-2024.202408053
[18]	陈炳辰, 王思真, 郭贝贝, 杨峰. 紫杉醇棕榈酸酯的合成及其脂质体的制备与处方研究 . 药学实践与服务, 2024, 42(9): 379-384, 410. doi: 10.12206/j.issn.2097-2024.202404062
[19]	刘汝雄, 杨万镇, 涂杰, 盛春泉. 铁死亡调控蛋白GPX4的小分子抑制剂研究进展 . 药学实践与服务, 2024, 42(9): 375-378. doi: 10.12206/j.issn.2097-2024.202312075
[20]	冯志惠, 邓仪卿, 叶冰, 安培, 张宏, 张海军. 雀梅藤石油醚提取物诱导三阴性乳腺癌细胞凋亡的实验研究 . 药学实践与服务, 2024, 42(6): 253-259. doi: 10.12206/j.issn.2097-2024.202311055

点击查看大图

计量

文章访问数: 7281
HTML全文浏览量: 867
PDF下载量: 399
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

真核延长因子eEF1A功能研究进展

doi: 10.3969/j.issn.1006-0111.2012.02.003

Advance in function of the eukaryotic elongation factor eEF1A

计量

真核延长因子eEF1A功能研究进展

doi: 10.3969/j.issn.1006-0111.2012.02.003

第二军医大学药学院药理学教研室, 上海 200433

English Abstract

Advance in function of the eukaryotic elongation factor eEF1A

Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai 200433, China

全文HTML

目录

留言板

真核延长因子eEF1A功能研究进展

doi: 10.3969/j.issn.1006-0111.2012.02.003

Advance in function of the eukaryotic elongation factor eEF1A

计量

出版历程

真核延长因子eEF1A功能研究进展

doi: 10.3969/j.issn.1006-0111.2012.02.003

第二军医大学药学院药理学教研室, 上海 200433

English Abstract

Advance in function of the eukaryotic elongation factor eEF1A

Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai 200433, China

全文HTML

目录